| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |